Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review.

Digestive diseases and sciences - 1 Jul 2023

Amaral Maria João, Oliveira Rui Caetano, Donato Paulo, Tralhão José Guilherme

Abstract excerpt

Pancreatic cancer is one of the most fatal malignancies, as approximately 80% of patients are at advanced stages by the time of diagnosis. The main reason for the poor overall survival is late diagnosis that is partially due to the lack of tools for early-stage detection. In addition, there are several challenges in evaluating response to treatment and predicting prognosis. In this article, we do a review of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Liquid Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36988759
DOI: 10.1007/s10620-023-07904-6
PMCID: PMC10293428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review.PMID 36988759Read ↗

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.Semantic proximity Read ↗

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Pancreatic biomarkers: could they be the answer?Semantic proximity Read ↗

Early detection of pancreatic cancer: Where are we now and where are we going?Semantic proximity Read ↗

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectivesSemantic proximity Read ↗

Molecular biology of pancreatic cancer.Semantic proximity Read ↗

Pancreatic cancer subtyping - the keystone of precision treatmentSemantic proximity Read ↗

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside TranslationSemantic proximity Read ↗

Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation?Semantic proximity Read ↗

Liquid biopsy in pancreatic cancer: the beginning of a new eraSemantic proximity Read ↗

Current status of molecular diagnostic approaches using liquid biopsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.